259 related articles for article (PubMed ID: 18497346)
1. Alterations in saliva steroid hormone levels after oral mifepristone administration in women with pregnancies of greater than 41 weeks' gestation.
Fassett MJ; Lachelin GC; McGarrigle HH; Wing DA
Reprod Sci; 2008 Apr; 15(4):394-9. PubMed ID: 18497346
[TBL] [Abstract][Full Text] [Related]
2. Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks' gestation.
Fassett MJ; Wing DA
Gynecol Obstet Invest; 2008; 65(2):112-5. PubMed ID: 17912003
[TBL] [Abstract][Full Text] [Related]
3. Mifepristone: effect on plasma corticotropin-releasing hormone, adrenocorticotropic hormone, and cortisol in term pregnancy.
Byrne JD; Wing DA; Fraser M; Fassett MJ; Goodwin TM; Challis JR
J Perinatol; 2004 Jul; 24(7):416-20. PubMed ID: 15152270
[TBL] [Abstract][Full Text] [Related]
4. Lack of normal increase in saliva estriol/progesterone ratio in women with labor induced at 42 weeks' gestation.
Moran DJ; McGarrigle HH; Lachelin GC
Am J Obstet Gynecol; 1992 Dec; 167(6):1563-4. PubMed ID: 1471666
[TBL] [Abstract][Full Text] [Related]
5. Modulation of free corticotrophin-releasing hormone, adrenal and placental steroid hormone levels induced by mifepristone during pregnancy.
Ceccaldi PF; Saada J; Nicolas M; Ducarme G; Blot P; Guibourdenche J; Luton D
Fetal Diagn Ther; 2012; 32(4):267-70. PubMed ID: 22759411
[TBL] [Abstract][Full Text] [Related]
6. Use of mifepristone to ripen the cervix and induce labor in term pregnancies.
Berkane N; Verstraete L; Uzan S; Boog G; Maria B
Am J Obstet Gynecol; 2005 Jan; 192(1):114-20. PubMed ID: 15672012
[TBL] [Abstract][Full Text] [Related]
7. Effect of antiprogesterone mifepristone followed by misoprostol on circulating leptin in early pregnancy.
Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O
Acta Obstet Gynecol Scand; 2005 Feb; 84(2):134-9. PubMed ID: 15683372
[TBL] [Abstract][Full Text] [Related]
8. Tissue and serum levels of steroid hormones and RU 486 after administration of mifepristone.
Wang JD; Shi WL; Zhang GQ; Bai XM
Contraception; 1994 Mar; 49(3):245-53. PubMed ID: 8200218
[TBL] [Abstract][Full Text] [Related]
9. Changes in rates of salivary estriol increases before parturition at term.
Hedriana HL; Munro CJ; Eby-Wilkens EM; Lasley BL
Am J Obstet Gynecol; 2001 Jan; 184(2):123-30. PubMed ID: 11174491
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of oral mifepristone to intravenous oxytocin for labor induction in women with prelabor rupture of membranes beyond 36 weeks' gestation.
Wing DA; Guberman C; Fassett M
Am J Obstet Gynecol; 2005 Feb; 192(2):445-51. PubMed ID: 15695985
[TBL] [Abstract][Full Text] [Related]
11. Effects of continuous elevated cortisol concentrations during oestrus on concentrations and patterns of progesterone, oestradiol and LH in the sow.
Brandt Y; Einarsson S; Ljung A; Lundeheim N; Rodríguez-Martínez H; Madej A
Anim Reprod Sci; 2009 Jan; 110(1-2):172-85. PubMed ID: 18308488
[TBL] [Abstract][Full Text] [Related]
12. [Mifepristone for induction of labor].
Su H; Li E; Weng L
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):676-80. PubMed ID: 9387530
[TBL] [Abstract][Full Text] [Related]
13. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
14. [RU 486 (mifepristone): a new tool for labor induction women at term with live fetus].
Frydman R; Taylor S; Paoli C; Pourade A
Contracept Fertil Sex (Paris); 1992 Dec; 20(12):1133-6. PubMed ID: 12344709
[TBL] [Abstract][Full Text] [Related]
15. Hormone analytical and carrier protein alternations following administration of mifepristone (RU 486) for termination of early pregnancy.
Klinger G; Carol W; Börner A; Michels W; Romero KR
Exp Clin Endocrinol; 1991 Mar; 97(1):63-7. PubMed ID: 1864315
[TBL] [Abstract][Full Text] [Related]
16. [Studies on changes in serum estrone, estradiol, estriol, DHA-S, and cortisol and urinary estriol excretion].
Ikeno N; Takahashi K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):99-106. PubMed ID: 3156195
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone-induced cervical ripening: structural, biomechanical, and molecular events.
Clark K; Ji H; Feltovich H; Janowski J; Carroll C; Chien EK
Am J Obstet Gynecol; 2006 May; 194(5):1391-8. PubMed ID: 16647925
[TBL] [Abstract][Full Text] [Related]
18. [Effect of mifepristone on the concentration of epidermal growth factor in serum and villi of early pregnant women].
Yang Q; Yang X; Xu W
Zhonghua Fu Chan Ke Za Zhi; 1998 May; 33(5):271-3. PubMed ID: 10682436
[TBL] [Abstract][Full Text] [Related]
19. Treatment with an inhibitor of catechol-O-methyltransferase activity reduces preterm birth and impedes cervical resistance to stretch in pregnant rats.
Wentz MJ; Shi SQ; Shi L; Salama SA; Harirah HM; Fouad H; Garfield RE; Al-Hendy A
Reproduction; 2007 Dec; 134(6):831-9. PubMed ID: 18042640
[TBL] [Abstract][Full Text] [Related]
20. [Observations on serum and amniotic fluid hormone levels and ultrastructure of uterine myometrium before and during term labor].
Yan J; Chen W
Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):391-4. PubMed ID: 7587572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
